Needle Free Injection Device Market By Product And Application - Global Industry Analysis And Forecast To 2023
Published On : June 2022 Pages : 190 Category: Medical Devices Report Code : HC06979
Industry Outlook and Trend Analysis
The Needle-Free Injection Device Market was worth USD 7.36 billion in 2017 and is expected to reach approximately USD 26.72 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 15.41% during the forecast period. Needle free injection technology (NFIT) includes an extensive variety of drug delivery systems that drive medication through the skin utilizing any of the powers as Lorentz, shock waves, pressure by gas or electrophoresis which pushes the medication through the skin, virtually invalidating the utilization of hypodermic needle. The devices accordingly are accessible in reusable forms. Rather than the customary syringes, NFIT not only provides the user opportunity from unnecessary pain but tranquilizes as solid pallets can be administered. The future of this innovation is promising guaranteeing painless and very proficient drug delivery.
Drivers and Restraints
Developing demand for self-administration and pain-free drug delivery is one of the key development stimulants of the market. The incorporation of these products is evaluated to advance patient's self-reliance alongside considerable reduction in hospital visits, in this manner decreasing clinic staff requirements and aggregate treatment cost. Furthermore, rapid progressions in technology are clearing path for these minimally invasive devices. Related advantages of such progressions incorporate moderate and controlled flow of medication into the body according to patient's needs, expanded portability, and minimal damage to the skin. Developing awareness in regards to the previously mentioned benefits is anticipated to make a rise in the interest for needle free drug delivery devices. One of the major disadvantages related with this innovation is postadministration "wetness" of the skin which may, if not dealt with, carry dust and other impurities.
Market Segmentation
The Needle-Free Injection Device Market is segmented on the basis of product and end user. Based on product the market is segmented into Powder Injections, Liquid Injections and Depot or Projectile Injection. On the basis of end user the market is segmented into Cosmetic Surgery Use and Drug Injection.
Regional Outlook and Trend Analysis
North America held the biggest income share of 41.0% in the worldwide market in 2017. This can be credited to increasing awareness among the patients in regards to the accessibility of novel products and expanding R&D ventures by conspicuous market players domiciled in this locale. Existence of well-structured repayment system is another factor boosting the provincial market. The Asia Pacific area holds noteworthy development potential.
Competitive Insights
The leading players in the market are Akra Dermo-Jet, PharmaJet, Glide Pharma, The National Medical Products Co. Ltd, Zogenix, Valeritas Holdings, Antares Pharma Inc, CROSSJECT and Inovio Pharmaceuticals Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Needle-Free Injection Device Market is segmented as follows-
By Product:
- Powder Injections
- Liquid Injections
- Depot or Projectile Injection
By End User:
- Cosmetic Surgery Use
- Drug Injection
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- South Africa
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2023?
- What will be the industry market growth from 2017 to 2023?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Needle Free Injection Device Market, By Product, Estimates and Forecast, 2014-2023 ($Million)
· Powder Injections
· Liquid Injections
· Depot or Projectile Injection
· Needle-Free Injection Device Market, By Application, Estimates and Forecast, 2014-2023 ($Million)
· Drug Injection
· Cosmetic Surgery Use
· Needle Free Injection Device Market, By Region, Estimates and Forecast, 2014-2023 ($Million)
· North America
§ North America Needle-Free Injection Device Market, By Country
o U.S. Needle-Free Injection Device Market
o Canada Needle-Free Injection Device Market
o Mexico Needle-Free Injection Device Market
· Europe
§ Europe Needle-Free Injection Device Market, By Country
o Germany Needle-Free Injection Device Market
o UK Needle-Free Injection Device Market
o France Needle-Free Injection Device Market
o Russia Needle-Free Injection Device Market
o Italy Needle-Free Injection Device Market
o Rest of Europe Needle-Free Injection Device Market
· Asia-Pacific
§ Asia-Pacific Needle-Free Injection Device Market, By Country
o China Needle-Free Injection Device Market
o Japan Needle-Free Injection Device Market
o South Korea Needle-Free Injection Device Market
o India Needle-Free Injection Device Market
o Southeast Asia Needle-Free Injection Device Market
o Rest of Asia-Pacific Needle-Free Injection Device Market
· South America
§ South America Needle-Free Injection Device Market
o Brazil Needle-Free Injection Device Market
o Argentina Needle-Free Injection Device Market
o Columbia Needle-Free Injection Device Market
o South Africa Needle-Free Injection Device Market
o Rest of South America Needle-Free Injection Device Market
· Middle East and Africa
§ Middle East and Africa Needle-Free Injection Device Market
o Saudi Arabia Needle-Free Injection Device Market
o UAE Needle-Free Injection Device Market
o Egypt Needle-Free Injection Device Market
o Nigeria Needle-Free Injection Device Market
o South Africa Needle-Free Injection Device Market
o Rest of MEA Needle-Free Injection Device Market
Table of Contents
Chapter 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Chapter 2. Executive Summary
2.1. Key Highlights
Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.3.1. Emerging Markets to Offer Lucrative Growth Opportunities
Chapter 4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market States and Outlook (2017-2023)
4.1.2. Canada Market States and Outlook (2017-2023)
4.1.3. Mexico Market States and Outlook (2017-2023)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market States and Outlook (2017-2023)
4.2.2. France Market States and Outlook (2017-2023)
4.2.3. UK Market States and Outlook (2017-2023)
4.2.4. Russia Market States and Outlook (2017-2023)
4.2.5. Italy Market States and Outlook (2017-2023)
4.2.6. Rest of Europe Market States and Outlook (2017-2023)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market States and Outlook (2017-2023)
4.3.2. Japan Market States and Outlook (2017-2023)
4.3.3. Korea Market States and Outlook (2017-2023)
4.3.4. India Market States and Outlook (2017-2023)
4.3.5. Rest of Asia-Pacific Market States and Outlook (2017-2023)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market States and Outlook (2017-2023)
4.4.2. Argentina Market States and Outlook (2017-2023)
4.4.3. Columbia Market States and Outlook (2017-2023)
4.4.4. Rest of South America Market States and Outlook (2017-2023)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market States and Outlook (2017-2023)
4.5.2. UAE Market States and Outlook (2017-2023)
4.5.3. Egypt Market States and Outlook (2017-2023)
4.5.4. Nigeria Market States and Outlook (2017-2023)
4.5.5. South Africa Market States and Outlook (2017-2023)
4.5.6. Rest of MEA Market States and Outlook (2017-2023)
Chapter 5. Needle-Free Injection Device Market, By Product
5.1. Introduction
5.2. Global Needle-Free Injection Device Sales, Revenue and Market Share by Product (2017-2027)
5.2.1. Global Needle-Free Injection Device Sales and Sales Share by Product (2017-2027)
5.2.2. Global Needle-Free Injection Device Revenue and Revenue Share by Product (2017-2027)
5.3. Powder Injections
5.3.1. Global Powder Injections Sales and Growth Rate (2017-2027)
5.4. Liquid Injections
5.4.1. Global Liquid Injections Sales and Growth Rate (2017-2027)
5.5. Depot or Projectile Injection
5.5.1. Global Depot or Projectile Injection Sales and Growth Rate (2017-2027)
Chapter 6. Needle-Free Injection Device Market, By Application
6.1. Introduction
6.2. Global Needle-Free Injection Device Sales, Revenue and Market Share by Application (2017-2027)
6.2.1. Global Needle-Free Injection Device Sales and Sales Share by Application (2017-2027)
6.2.2. Global Needle-Free Injection Device Revenue and Revenue Share by Application (2017-2027)
6.3. Drug Injection
6.3.1. Global Drug Injection Sales and Growth Rate (2017-2027)
6.4. Cosmetic Surgery Use
6.4.1. Global Cosmetic Surgery Use Sales and Growth Rate (2017-2027)
Chapter 7. Needle-Free Injection Device Market, By Region
7.1. Introduction
7.2. Global Needle-Free Injection Device Sales, Revenue and Market Share by Regions
7.2.1. Global Needle-Free Injection Device Sales by Regions (2017-2027)
7.2.2. Global Needle-Free Injection Device Revenue by Regions (2017-2027)
7.3. North America Needle-Free Injection Device by Countries
7.3.1. North America Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.3.2. North America Needle-Free Injection Device Revenue and Growth Rate (2017-2027)
7.3.3. North America Needle-Free Injection Device Sales by Countries (2017-2027)
7.3.4. North America Needle-Free Injection Device Revenue (Million USD) by Countries (2017-2027)
7.3.5. U.S.
7.3.5.1. United States Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.3.5.2. United States Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.6. Canada
7.3.6.1. Canada Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.3.6.2. Canada Needle-Free Injection Device Sales (Millions USD) and Growth Rate (2017-2027)
7.3.7. Mexico
7.3.7.1. Mexico Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.3.7.2. Mexico Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Needle-Free Injection Device by Countries
7.4.1. Europe Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.4.2. Europe Needle-Free Injection Device Revenue and Growth Rate (2017-2027)
7.4.3. Europe Needle-Free Injection Device Sales by Countries (2017-2027)
7.4.4. Europe Needle-Free Injection Device Revenue (Million USD) by Countries (2017-2027)
7.4.5. Germany
7.4.5.1. Germany Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.4.5.2. Germany Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. UK
7.4.6.1. UK Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.4.6.2. UK Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. France
7.4.7.1. France Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.4.7.2. France Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Russia
7.4.8.1. Russia Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.4.8.2. Russia Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.9. Italy
7.4.9.1. Italy Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.4.9.2. Italy Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.10. Rest of Europe
7.4.10.1. Rest of Europe Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.4.10.2. Rest of Europe Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific
7.5.1. Asia-Pacific Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Needle-Free Injection Device Revenue and Growth Rate (2017-2027)
7.5.3. Asia-Pacific Needle-Free Injection Device Sales by Countries (2017-2027)
7.5.4. Asia-Pacific Needle-Free Injection Device Revenue (Million USD) by Countries (2017-2027)
7.5.5. China
7.5.5.1. China Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.5.5.2. China Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. Japan
7.5.6.1. Japan Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.5.6.2. Japan Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6.3.
7.5.7. Korea
7.5.7.1. Korea Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.5.7.2. Korea Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. India
7.5.8.1. India Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.5.8.2. India Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.9. Southeast Asia
7.5.9.1. Southeast Asia Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.5.9.2. Southeast Asia Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.10. Rest of Asia-Pacific
7.5.10.1. Rest of Asia-Pacific Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.5.10.2. Rest of Asia-Pacific Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America
7.6.1. South America Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.6.2. South America Needle-Free Injection Device Revenue and Growth Rate (2017-2027)
7.6.3. South America Needle-Free Injection Device Sales by Countries (2017-2027)
7.6.4. South America Needle-Free Injection Device Revenue (Million USD) by Countries (2017-2027)
7.6.5. Brazil
7.6.5.1. Brazil Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.6.5.2. Brazil Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Argentina
7.6.6.1. Argentina Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.6.6.2. Argentina Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.7. Columbia
7.6.7.1. Columbia Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.6.7.2. Columbia Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.8. Rest of South America
7.6.8.1. Rest of South America Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.6.8.2. Rest of South America Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa
7.7.1. Middle East and Africa Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Needle-Free Injection Device Revenue and Growth Rate (2017-2027)
7.7.3. Middle East and Africa Needle-Free Injection Device Sales by Countries (2017-2027)
7.7.4. Middle East and Africa Needle-Free Injection Device Revenue (Million USD) by Countries (2017-2027)
7.7.5. Saudi Arabia
7.7.5.1. Saudi Arabia Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.7.5.2. Saudi Arabia Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. United Arab Emirates
7.7.6.1. United Arab Emirates Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.7.6.2. United Arab Emirates Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. Egypt
7.7.7.1. Egypt Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.7.7.2. Egypt Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Nigeria
7.7.8.1. Nigeria Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.7.8.2. Nigeria Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. South Africa
7.7.9.1. South Africa Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.7.9.2. South Africa Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.10. Rest of Middle East and Africa
7.7.10.1. Rest of Middle East and Africa Needle-Free Injection Device Sales and Growth Rate (2017-2027)
7.7.10.2. Rest of Middle East and Africa Needle-Free Injection Device Revenue (Millions USD) and Growth Rate (2017-2027)
Chapter 8. Company Profiles
8.1. Zogenix
8.1.1. Business Overview
8.1.2. Product Portfolio
8.1.3. Strategic Developments
8.1.4. Sales, Revenue and Market Share
8.2. Inovio
8.2.1. Business Overview
8.2.2. Product Portfolio
8.2.3. Strategic Developments
8.2.4. Sales, Revenue and Market Share
8.3. Glide Pharma
8.3.1. Business Overview
8.3.2. Product Portfolio
8.3.3. Strategic Developments
8.3.4. Sales, Revenue and Market Share
8.4. Akra Dermojet
8.4.1. Business Overview
8.4.2. Product Portfolio
8.4.3. Strategic Developments
8.4.4. Sales, Revenue and Market Share
8.5. Crossject Medical Technology
8.5.1. Business Overview
8.5.2. Product Portfolio
8.5.3. Strategic Developments
8.5.4. Sales, Revenue and Market Share
8.6. Injex Pharma
8.6.1. Business Overview
8.6.2. Product Portfolio
8.6.3. Strategic Developments
8.6.4. Sales, Revenue and Market Share
8.7. Eternity Healthcare
8.7.1. Business Overview
8.7.2. Product Portfolio
8.7.3. Strategic Developments
8.7.4. Sales, Revenue and Market Share
8.8. Antares Pharma
8.8.1. Business Overview
8.8.2. Product Portfolio
8.8.3. Strategic Developments
8.8.4. Sales, Revenue and Market Share
8.9. Valeritas
8.9.1. Business Overview
8.9.2. Product Portfolio
8.9.3. Strategic Developments
8.9.4. Sales, Revenue and Market Share
8.10. Medical International Technologies
8.10.1. Business Overview
8.10.2. Product Portfolio
8.10.3. Strategic Developments
8.10.4. Sales, Revenue and Market Share
Chapter 9. Global Needle-Free Injection Device Market Competition, by Manufacturer
9.1. Global Needle-Free Injection Device Sales and Market Share by Manufacturer (2017-2017)
9.2. Global Needle-Free Injection Device Revenue and Market Share by Manufacturer (2017-2017)
9.3. Global Needle-Free Injection Device Price by Manufacturer (2017-2017)
9.4. Top 5 Needle-Free Injection Device Manufacturer Market Share
9.5. Market Competition Trend
Chapter 10. Needle-Free Injection Device Market Forecast (2027-2023)
10.1. Global Needle-Free Injection Device Sales, Revenue (Millions USD) and Growth Rate (2027-2023)
10.2. Needle-Free Injection Device Market Forecast by Regions (2027-2023)
10.2.1. North America Needle-Free Injection Device Market Forecast (2027-2023)
10.2.1.1. United States Needle-Free Injection Device Market Forecast (2027-2023)
10.2.1.2. Canada Needle-Free Injection Device Market Forecast (2027-2023)
10.2.1.3. Mexico Needle-Free Injection Device Market Forecast (2027-2023)
10.2.2. Europe Needle-Free Injection Device Market Forecast (2027-2023)
10.2.2.1. Germany Needle-Free Injection Device Market Forecast (2027-2023)
10.2.2.2. United Kingdom Needle-Free Injection Device Market Forecast (2027-2023)
10.2.2.3. France Needle-Free Injection Device Market Forecast (2027-2023)
10.2.2.4. Russia Needle-Free Injection Device Market Forecast (2027-2023)
10.2.2.5. Italy Needle-Free Injection Device Market Forecast (2027-2023)
10.2.2.6. Rest of the Europe Needle-Free Injection Device Market Forecast (2027-2023)
10.2.3. Asia-Pacific Needle-Free Injection Device Market Forecast (2027-2023)
10.2.3.1. China Needle-Free Injection Device Market Forecast (2027-2023)
10.2.3.2. Japan Needle-Free Injection Device Market Forecast (2027-2023)
10.2.3.3. Korea Needle-Free Injection Device Market Forecast (2027-2023)
10.2.3.4. India Needle-Free Injection Device Market Forecast (2027-2023)
10.2.3.5. Southeast Asia Needle-Free Injection Device Market Forecast (2027-2023)
10.2.3.6. Rest of Asia-Pacific Needle-Free Injection Device Market Forecast (2027-2023)
10.2.4. South America Needle-Free Injection Device Market Forecast (2027-2023)
10.2.4.1. Brazil Needle-Free Injection Device Market Forecast (2027-2023)
10.2.4.2. Argentina Needle-Free Injection Device Market Forecast (2027-2023)
10.2.4.3. Columbia Needle-Free Injection Device Market Forecast (2027-2023)
10.2.4.4. Rest of South America Needle-Free Injection Device Market Forecast (2027-2023)
10.2.5. Middle East and Africa Needle-Free Injection Device Market Forecast (2027-2023)
10.2.5.1. Saudi Arabia Needle-Free Injection Device Market Forecast (2027-2023)
10.2.5.2. UAE Needle-Free Injection Device Market Forecast (2027-2023)
10.2.5.3. Egypt Needle-Free Injection Device Market Forecast (2027-2023)
10.2.5.4. Nigeria Needle-Free Injection Device Market Forecast (2027-2023)
10.2.5.5. South Africa Needle-Free Injection Device Market Forecast (2027-2023)
10.2.5.6. Rest of MEA Needle-Free Injection Device Market Forecast (2027-2023)
10.3. Needle-Free Injection Device Market Forecast by Product (2027-2023)
10.3.1. Global Needle-Free Injection Device Sales Forecast by Product (2027-2023)
10.3.2. Global Needle-Free Injection Device Sales Market Share Forecast by Product (2027-2023)
10.4. Needle-Free Injection Device Market Forecast by Application (2027-2023)
10.4.1. Global Needle-Free Injection Device Sales Forecast by Application (2027-2023)
10.4.2. Global Needle-Free Injection Device Sales Market Share Forecast by Application (2027-2023)
List of Tables
(*You can glance through the list of Tables and Figures when you view the sample copy of Needle-Free Injection Device Market.)
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|